TLR9 and systemic sclerosis: In agreement with these studies, we reported that TIM-1 and IL-10 were preferentially co-expressed in transitional B cells from healthy donors upon BCR and TLR9 activation; however, this population is significantly decreased in patients with systemic sclerosis (SSc).